Table of Content

Chapter 1 Executive Summary
Scope of Report
Market Summary

Chapter 2 Market Overview
Market Definitions
Over-the-counter (OTC) Drugs
Vitamins and Dietary Supplements
Industry Overview
Macroeconomic Analysis
Porter’s Five Forces Analysis
Bargaining Power of Buyers (High)
Bargaining Power of Suppliers (Moderate to Low)
Threat of New Entrants (Moderate)
Threat of Substitutes (Low)
Industry Competition (High)

Chapter 3 Market Dynamics
Market Drivers
Increasing Trend Toward Self-Care and Preventive Care
Changing Demographics Resulting in Aging Population
Increasing Pressure on Public Health Systems
Premiumization and Innovation Driving Pricing
Rising Online Sales Channels and Growth of Telehealth Platforms
Market Restraints
Increases in the Availability and Acceptance of Private-Label Brands
Threat from Counterfeit Products
Presence of Alternative Methods
Impact of Seasonality
Market Opportunities
Growing Middle Class in Emerging Economies
Growing Demand for Women’s Health and Cognitive Health Support Products
Shift Toward Herbal and Organic Products
E-Commerce and Direct-to-Consumer Sales
Key Takeaways

Chapter 4 Regulatory Landscape
U.S.
OTC Drugs
Vitamins and Dietary Supplements
Europe
OTC Drugs
Vitamins and Dietary Supplements
Asia-Pacific
OTC Drugs
Vitamins and Dietary Supplements

Chapter 5 Emerging Technologies and Developments
Increased Awareness of Ingredient Labeling
Brand Extension Fueled by Innovation
Rx-to-OTC Switch

Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Product Type
Vitamins and Dietary Supplements
Market Overview
Key Takeaways
Market Revenue and Forecast
Vitamins and Dietary Supplements Market, by Point of Sale
Retail Pharmacies and Stores
E-Commerce
Other Points of Sales
OTC Drugs
Market Overview
Key Takeaways
Market Revenue and Forecast, by Product Type
Respiratory Treatments
Pain Relief
Digestive Health
Dermatological Drugs
Oral Medical Care
Eye Care
Smoking Cessation
OTC Drugs Market, by Point of Sale
Retail Pharmacies and Stores
E-Pharmacies
Geographic Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America

Chapter 7 Competitive Intelligence
Key Takeaways
OTC Drugs
Vitamins and Dietary Supplements
Key Developments and Strategies

Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective
Introduction to ESG
Environment
Social
Governance
ESG Risk Ratings
Conclusion

Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AMWAY CORP.
BAYER AG
DSM- FIRMENICH
HALEON GROUP OF CO.
HERBALIFE LTD.
KENVUE
NESTLE HEALTH SCIENCE
OPELLA HEALTHCARE GROUP SAS
PHARMAVITE
PROCTER & GAMBLE
RECKITT
STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Emerging Start-ups/ Market Disruptors



List of Figures


Summary Figure : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis
Figure 2 : Market Dynamics Snapshot
Figure 3 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 4 : Global Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 5 : Global Market Shares of OTC Drugs, by Product Type, 2024
Figure 6 : Global Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 7 : Global Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Region, 2024
Figure 8 : North American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 9 : North American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 10 : North American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 11 : U.S. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 12 : Canadian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 13 : Mexican Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 14 : European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 15 : European Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 16 : European Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 17 : German Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 18 : U.K. Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 19 : French Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 20 : Italian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 21 : Rest of European Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 22 : Asia-Pacific Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 23 : Asia-Pacific Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 24 : Asia-Pacific Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 25 : Chinese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 26 : Japanese Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 27 : Indian Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 28 : Rest of APAC Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 29 : Middle Eastern and African Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 30 : Middle Eastern and African Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 31 : Middle Eastern and African Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 32 : South American Market Shares of OTC Drugs, Vitamins and Dietary Supplements, by Product Type, 2024
Figure 33 : South American Market Shares of Vitamins and Dietary Supplements, by Point of Sale, 2024
Figure 34 : South American Market Shares of OTC Drugs, by Point of Sale, 2024
Figure 35 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 37 : Bayer AG: Revenue Shares, by Business Unit, FY 2024
Figure 38 : Bayer AG: Revenue Shares, by Country/Region, FY 2024
Figure 39 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2024
Figure 40 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2024
Figure 41 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2024
Figure 42 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2024
Figure 43 : Herbalife Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 44 : Herbalife Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 45 : Kenvue: Revenue Shares, by Business Unit, FY 2024
Figure 46 : Kenvue: Revenue Shares, by Country/Region, FY 2024
Figure 47 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 48 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 49 : Reckitt: Revenue Shares, by Business Unit, FY 2024
Figure 50 : Reckitt: Revenue Shares, by Country/ Region, FY 2024
Figure 51 : Stada Arzneimittel AG: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Stada Arzneimittel AG: Revenue Shares, by Country/ Region, FY 2023
Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Shares, by Business Unit, 2024

List of Tables


Summary Table : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 1 : Benefits of Over-the-Counter (OTC) Drugs
Table 2 : Porter’s Five Forces: Rating Scale
Table 3 : Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
Table 4 : Asia-Pacific: Regulatory Landscape
Table 5 : Rx-to-OTC Switch Drugs, 2020–2024*
Table 6 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 7 : Common Dietary Supplements
Table 8 : Specialty Dietary Supplements
Table 9 : Global Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 10 : Global Market for OTC Drugs, by Product Type, Through 2030
Table 11 : Common OTC Respiratory Drugs
Table 12 : Most Common OTC Pain Relievers
Table 13 : Digestive Health OTC Drugs
Table 14 : Most Common OTC Dermatological Drugs
Table 15 : OTC Eye Care Drugs
Table 16 : OTC Smoking Cessation Products
Table 17 : Global Market for OTC Drugs, by Point of Sale, Through 2030
Table 18 : Global Market for OTC Drugs, Vitamins and Dietary Supplements, by Region, Through 2030
Table 19 : North American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 20 : North American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 21 : North American Market for OTC Drugs, by Point of Sale, Through 2030
Table 22 : North American Population and GDP Data, by Country, 2023
Table 23 : U.S. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 24 : Canadian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 25 : Mexican Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 26 : European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 27 : European Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 28 : European Market for OTC Drugs, by Point of Sale, Through 2030
Table 29 : German Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 30 : U.K. Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 31 : French Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 32 : Italian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 33 : Rest of European Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 34 : Asia-Pacific Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 35 : Asia-Pacific Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 36 : Asia-Pacific Market for OTC Drugs, by Point of Sale, Through 2030
Table 37 : Chinese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 38 : Japanese Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 39 : Indian Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 40 : Rest of APAC Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 41 : Middle Eastern and African Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 42 : Middle Eastern and African Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 43 : Middle Eastern and African Market for OTC Drugs, by Point of Sale, Through 2030
Table 44 : South American Market for OTC Drugs, Vitamins and Dietary Supplements, by Product Type, Through 2030
Table 45 : South American Market for Vitamins and Dietary Supplements, by Point of Sale, Through 2030
Table 46 : South American Market for OTC Drugs, by Point of Sale, Through 2030
Table 47 : OTC Drugs: Market Player Share Analysis, 2024
Table 48 : Leading Vitamin and Dietary Supplement Companies and Their Key Brands, 2024
Table 49 : Key Developments and Strategies, 2023-2025
Table 50 : ESG Pillars for OTC Drugs, Vitamins and Dietary Supplements Market
Table 51 : ESG Risk Rankings for OTC Drugs, Vitamins and Dietary Supplements Companies, 2025*
Table 52 : Report Sources
Table 53 : Abbreviations Used in This Report
Table 54 : Abbott: Company Snapshot
Table 55 : Abbott: Financial Performance, FY 2023 and 2024
Table 56 : Abbott: Product Portfolio
Table 57 : Amway Corp.: Company Snapshot
Table 58 : Amway Corp.: Product Portfolio
Table 59 : Bayer AG: Company Snapshot
Table 60 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 61 : Bayer AG: Product Portfolio
Table 62 : Bayer AG: News/Key Developments, 2024 and 2025
Table 63 : DSM-Firmenich: Company Snapshot
Table 64 : DSM-Firmenich: Financial Performance, FY 2023 and 2024
Table 65 : DSM-Firmenich: Product Portfolio
Table 66 : DSM-Firmenich: News/Key Developments, 2023 and 2024
Table 67 : Haleon Group of Co.: Company Snapshot
Table 68 : Haleon Group of Co.: Financial Performance, FY 2023 and 2024
Table 69 : Haleon Group of Co.: Product Portfolio
Table 70 : Haleon Group of Co.: News/Key Developments, 2023
Table 71 : Herbalife Ltd.: Company Snapshot
Table 72 : Herbalife Ltd.: Financial Performance, FY 2023 and 2024
Table 73 : Herbalife Ltd.: Product Portfolio
Table 74 : Herbalife Ltd.: News/Key Developments, 2023
Table 75 : Kenvue: Company Snapshot
Table 76 : Kenvue: Financial Performance, FY 2023 and 2024
Table 77 : Kenvue: Product Portfolio
Table 78 : Kenvue: News/Key Developments, 2023
Table 79 : Nestl? Health Science: Company Snapshot
Table 80 : Nestl? Health Science: Financial Performance, FY 2023 and 2024
Table 81 : Nestl? Health Science: Product Portfolio
Table 82 : Opella Healthcare Group SAS: Company Snapshot
Table 83 : Opella Healthcare Group SAS: Product Portfolio
Table 84 : Opella Healthcare Group SAS: News/Key Developments, 2023-2025
Table 85 : Pharmavite: Company Snapshot
Table 86 : Pharmavite: Product Portfolio
Table 87 : Pharmavite: News/Key Developments, 2023 and 2024
Table 88 : Procter & Gamble: Company Snapshot
Table 89 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 90 : Procter & Gamble: Product Portfolio
Table 91 : Reckitt: Company Snapshot
Table 92 : Reckitt: Financial Performance, FY 2023 and 2024
Table 93 : Reckitt: Product Portfolio
Table 94 : Reckitt: News/Key Developments, 2024
Table 95 : Stada Arzneimittel AG: Company Snapshot
Table 96 : Stada Arzneimittel AG: Financial Performance, FY 2022 and 2023
Table 97 : Stada Arzneimittel AG: Product Portfolio
Table 98 : Stada Arzneimittel AG: News/Key Developments, 2023 and 2024
Table 99 : Taisho Pharmaceutical Holdings Co. Ltd.: Company Snapshot
Table 100 : Taisho Pharmaceutical Holdings Co. Ltd.: Product Portfolio
Table 101 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 102 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2023 and 2024
Table 103 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 104 : List of Few Emerging Startups/ Market Disruptors